Showing 41-50 of 454 results
Helsinn is pleased to announce that on Friday October 4th, in the presence of Biasca's Town Mayor, Mr. Jean- François Dominé and Director of the professional training Division, Department of education, culture and sport, Mr. Paolo Colombo, the young award-winning students received 10 Helsinn Advanced Synthesis SA educational scholarships value of CHF 55.000- for the academic ye...
Helsinn and Chugai Pharma Marketing enter into agreement for rights of Anamorelin, currently in development for treatment of anorexia-cachexia syndrome related to non-small cell lung cancer in top EU markets
Helsinn Birex Pharmaceuticals' (HBP) commitment and excellence in health and safety over many years was once again acknowledged with two coveted awards at the 22nd Annual NAtional Irish Safety Organisation/Northern Ireland Safety Group (NISO/NISG) Safety Awards ceremony, which took place il Galaway on October 4th 2013.
Helsinn Group, the independent, privately - owned, Swiss pharmaceutical company, with a worldwide presence built over 35 years, lands in China. Helsinn's Representative Office was officially in augurated in Beijing, PRC yesterday.
Seeking indication for prevention of chemioterapy-induced nausea and vomiting
Helsinn Group grants exclusive distribution and licensing rights to Italfarmaco for the commercialization of its compound currently in development for the treatment of anorexia-cachexia syndrome related to non-small cell lung cancer (N cell lung cancer (NSCLC).
Il polo chimico del Gruppo Helsinn redige, prima organizzazione privata con sede nel Canton Ticino, il proprio rapporto secondo le strettissime ed innovative linee guida del Global Reporting Initiative (GRI) ‐ Riccardo Braglia: "Helsinn Advanced Synthesis SA è un "Good Corporate Citizen", un "Buon Cittadino" che vuole contribuire a far crescere la nostra regione e a sostenere i...
The educational scholarships of 5.000.-CHF each, sponsored by Helsinn Advanced Synthesis Biasca, were awarded to 11 students living in Canton Ticino who are attending professional or academic training in the chemical, pharmaceutical, biological, biochemical or in similar fields; the scholarships have therefore been given to those carrying out an internship or attending the Fede...
The data presented at the SIOP congress in Toronto, 22-24 October, today, October 23rd derive from a large randomized trial.
FDA Approves AKYNZEO® (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)